Chitosan-modified cholesterol-free liposomes for improving the oral bioavailability of progesterone

被引:41
|
作者
Wang, Mei [1 ]
Liu, Meng [3 ]
Xie, Tingting [4 ]
Zhang, Bing-Feng [2 ]
Gao, Xiao-Li [1 ]
机构
[1] Xinjiang Med Univ, Dept Pharmaceut, Coll Pharm, Urumqi, Peoples R China
[2] Yichun Univ, Coll Chem & Bioengn, Yichun, Peoples R China
[3] Xinjiang Med Univ, Affiliated Tumor Hosp, Urumqi, Peoples R China
[4] Peoples Liberat Army Gen Hosp, Dept Pharmaceut Care, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Progesterone; Oral bioavailability; Chitosan; Cholesterol-free liposomes; INSULIN-LOADED LIPOSOMES; DRUG-DELIVERY; BILE-SALTS; CANCER; SYSTEM;
D O I
10.1016/j.colsurfb.2017.08.028
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Based on the structurally similar properties of progesterone and cholesterol, chitosan-coated cholesterol free liposomes (CS-Lipo/Prog) were formulated. CS-Lipo/Prog are spherical and uniform in size (662.1 +/- 19.3 nm) with positive potential (28.19 +/- 1.97 mV). The average drug entrapment efficiency (EE) is approximately 80%. The in vitro release profile of CS-Lipo/Prog shows sustained release. The in vitro stability evaluation demonstrated that CS-Lipo/Prog can efficiently shield Prog from degradation in the gastrointestinal tract. CS-Lipo/Prog showed a longer MRT and higher AUC(0-infinite) after oral administration to mice than in the control group (progesterone-free). The relative bioavailability of CS-Lipo/Prog was higher than that of progesterone soft capsules (QINING (R)) and Lipo/Prog. Collectively, these findings suggest that cholesterol-free chitosan-coated liposomes are a promising alternative for improving the oral bioavailability of progesterone. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:580 / 585
页数:6
相关论文
共 50 条
  • [21] Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes
    Song, Zilin
    Yin, Jiaojiao
    Xiao, Peifu
    Chen, Jin
    Gou, Jingxin
    Wang, Yanjiao
    Zhang, Yu
    Yin, Tian
    Tang, Xing
    He, Haibing
    PHARMACEUTICS, 2021, 13 (02) : 1 - 20
  • [22] Improving oral bioavailability of water-insoluble idebenone with bioadhesive liposomes
    Qian, Xiandi
    Wang, Guanru
    Li, Jie
    Zhang, Xinyue
    Zhang, Minghui
    Yang, Qingmin
    Zhang, Zhiwen
    Li, Yaping
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 75
  • [23] pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery
    Yao, Yao
    Su, Zhihui
    Liang, Yanchao
    Zhang, Na
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 6185 - 6198
  • [24] Chitosan-modified dihydromyricetin liposomes promote the repair of liver injury in mice suffering from diabetes mellitus
    Ding, Qiteng
    Liu, Xinglong
    Zhang, Shuai
    Chai, Guodong
    Ma, Shuang
    Sun, Shuwen
    Shen, Liqian
    Gao, Yang
    Ding, Chuanbo
    Zhao, Ting
    Liu, Wencong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 273
  • [25] N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: Preparation, characterization, and pharmacokinetics
    Qu, Guowei
    Wu, Xiaoli
    Yin, Lifang
    Zhang, Can
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (01) : 46 - 51
  • [26] Chitosan-modified graphene oxide as a modifier for improving the structure and performance of forward osmosis membranes
    Du, Chun-Hui
    Zhang, Xin-Yi
    Wu, Chun-Jin
    POLYMERS FOR ADVANCED TECHNOLOGIES, 2020, 31 (04) : 807 - 816
  • [27] Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment
    Zhang, Wen
    Zhang, Xinping
    Lv, Xinyi
    Qu, Ao
    Liang, Wenjing
    Wang, Limin
    Zhao, Pei
    Wu, Zijian
    MOLECULES, 2024, 29 (06):
  • [28] Elaboration of polymersomes versus conventional liposomes for improving oral bioavailability of the anticancer flutamide
    Youssef, Shams F.
    Elnaggar, Yosra S. R.
    Abdallah, Ossama Y.
    NANOMEDICINE, 2018, 13 (23) : 3025 - 3036
  • [29] Chitosan-Modified Cationic Amino Acid Nanoparticles as a Novel Oral Delivery System for Insulin
    Abbad, Sarra
    Zhang, Zhenhai
    Waddad, Ayman Y.
    Munyendo, Were L. L.
    Lv, Huixia
    Zhou, Jianping
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2015, 11 (03) : 486 - 499
  • [30] Chitosan-modified mesoporous silica nanoparticles for the oral delivery of Norcantharidin: In vitro and in vivo assessment
    Huo, Daixia
    An, Qiuxu
    Li, Mingzhe
    Lv, Xiaojie
    MICROPOROUS AND MESOPOROUS MATERIALS, 2024, 369